Skip to main content

Weight Loss (Obesity / Overweight) News (Page 24)

Related terms: Weight Gain, Overweight, Weightloss, Anorexiants, Obesity, Obese, Weight Loss, Loose Weight, Lost Weight, diet drugs, diet medications, anti-obesity medications, Weight Loss Medications

Widening Disparities Seen in Youth Obesity

WEDNESDAY, May 15, 2024 – In the 2019 to 2020 school year, 20.9 percent of New York City elementary and middle school students had obesity, and 6.4 percent had severe obesity, according to a study...

For Women With Obesity, Risk for Breast Cancer Drops After Bariatric Surgery

THURSDAY, May 16, 2024 – For women with obesity, the risk for breast cancer is reduced after bariatric surgery, according to a study published online May 15 in JAMA Surgery. Felipe M. Kristensson,...

Childhood Weight Status May Stratify Mortality Risk in Adults With Obesity

THURSDAY, May 16, 2024 – In adults with obesity, childhood weight status may stratify mortality risk, according to a study presented at the annual meeting of the European Congress on Obesity, hosted...

Activity Tracker, Scale Plus Phone App May Aid Weight Loss

THURSDAY, May 16, 2024 – Weight loss is similar for individuals using a wireless feedback system (WFS) that provides daily information on lifestyle change and weight loss versus the same system...

Four in 10 Adults With Diabetes Report Taking a GLP-1 Receptor Agonist

TUESDAY, May 14, 2024 – One in eight adults (12 percent) say they have ever taken a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and 6 percent say they are currently using one, according to...

One Key to Weight Loss for Men: Competing for Cash

WEDNESDAY, May 15, 2024 – A competitive game with a potential cash reward appeared to help overweight British men lose weight, researchers report. The incentive was winning the "Game of Stones" – a...

GLP-1 Receptor Agonist Use Increases Likelihood of Antidepressant Prescription

WEDNESDAY, May 15, 2024 – Individuals taking glucagon-like peptide (GLP)-1 receptor agonists have a greater risk for subsequently being dispensed antidepressants, according to a study published...

Text Messages + Financial Incentives Boost Weight Loss at 12 Months

WEDNESDAY, May 15, 2024 – Among men with obesity, an intervention with text messaging plus financial incentive significantly improves weight loss compared with a control group, according to a study...

Smoking During Pregnancy Could Raise Baby's Odds for Obesity Later

TUESDAY, May 14, 2024 – Women who smoke during pregnancy run a higher risk of their kids becoming overweight or obese, and researchers now think they know one reason why. Children born of moms who...

More Studies Support Wegovy's Long-Term Weight-Loss Benefits

TUESDAY, May 14, 2024 – Semaglutide – the active ingredient in the blockbuster weight-loss drugs Ozempic and Wegovy – can produce long-term weight and heart health benefits, a pair of new studies...

Most Slow Responders to Tirzepatide Do Lose Clinically Meaningful Weight

TUESDAY, May 14, 2024 – Among slow responders to tirzepatide treatment at week 12, 90 percent went on to achieve clinically meaningful weight reduction (≥5 percent) by week 72, according to a study p...

Wegovy Approved in the US for Cardiovascular Risk Reduction in People with Overweight or Obesity and Established Cardiovascular Disease

Bagsværd, Denmark, 8 March 2024 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved a label expansion for Wegovy based on a supplemental New Drug Application (s...

A Cardiologist Answers Your Questions on New Weight-Loss Meds, Ozempic and Zepbound

MONDAY, Feb. 12, 2024 – Weight loss drugs like Ozempic and Zepbound can lead to better heart health for people struggling with excess weight or diabetes, a University of Michigan cardiologist says....

A Cardiologist Answers Your Questions on New Weight-Loss Meds, Ozempic and Zepbound

MONDAY, Feb. 12, 2024 – Weight loss drugs like Ozempic and Zepbound can lead to better heart health for people struggling with excess weight or diabetes, a University of Michigan cardiologist says....

FDA Approves Zepbound (tirzepatide) for Chronic Weight Management

INDIANAPOLIS, Nov. 8, 2023 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company's (NYSE: LLY) Zepbound™ (tirzepatide) injection, the first and only obesity t...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related drug support groups

bupropion, phentermine, Contrave, Ozempic, amphetamine, Saxenda, methamphetamine, Mounjaro, topiramate, view more... Wegovy, semaglutide, methylphenidate, Qsymia, Zepbound, liraglutide, Adipex-P, tirzepatide, Alli, orlistat, garcinia cambogia, desvenlafaxine, dulaglutide